Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 3Zollinger-Ellison Syndrome 2Gastroesophageal Reflux 2Barrett Esophagus 2Xerostomia 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomach Ulcer 1Stomach Neoplasms 1Pseudomyxoma Peritonei 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia 1Mucositis 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, B-Cell 1Hemorrhage 1Heartburn 1Head and Neck Neoplasms 1Esophagitis, Peptic 1Endometrial Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoid Tumor 1Appendiceal Neoplasms 1

Interventions

pembrolizumab 155Gemcitabine 139Capecitabine 121Paclitaxel 118Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 92Cisplatin 89Irinotecan 87Carboplatin 84Radiosurgery 83Cyclophosphamide 70Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × Lansoprazole × Clear all
NCT02625259 2018-01-08

A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants

Takeda

Phase 1 Completed
54 enrolled 16 charts
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡